Autologous bone marrow transplantation for second or greater complete remission of acute myeloid leukaemia and acute lymphoblastic leukaemia.
Twenty patients with acute leukaemia in second or greater complete remission have undergone autologous bone marrow transplantation (ABMT) in our centre. Twelve patients had acute myeloid leukaemia (AML) and eight patients had acute lymphoblastic leukaemia (ALL). Six of the patients treated for AML remain in CR. Of the eight patients with ALL, all have died within one year of transplantation. In the patients with AML there was no relationship between the duration of previous CR and outcome of ABMT.
Ager
S
S
Department of Haematology, Addenbrooke's Hospital, Cambridge, England, UK.
Broadbent
V
V
Marcus
R E
RE
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007951:Leukemia, Myeloid / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D012074:Remission Induction; D012189:Retrospective Studies; D014182:Transplantation, Autologous